Midas Letter

WELL Health Technologies Corp (CVE:WELL) (OTCMKTS:WLYYF) (FRA:W7V) CEO Hamed Shabazi shares the company’s plans to modernize and digitize health information in Canada. Shabazi recognized that the lack of scale in the Canadian health system was a barrier to digitalization so WELL Health to matters into its own hands and now the company is the largest owner of clinics in British Columbia. 600,000 patients visit WELL Health clinics annually and most of the care provided at its clinics is covered by provincial health care. The Canadian Health care space is a $250 billion industry and WELL Health plans to grow its network of clinics nationally and internationally. Despite the company’s participation in direct patient care, Shabazi anticipates WELL Health’s emergence as a digital medical service provider.

Original article: VIDEO: WELL Health Technologies Corp (CVE:WELL) Digitizing Canadian Health Information

©2018 Midas Letter. All Rights Reserved.

Green Relief Inc President Steve LeBlanc discusses the company’s plans to go public. Green Relief has a valuation of $400 million and is looking to raise $45 million in its latest financing round. The company grows all of its cannabis with aquaponics, the most sustainable form of agricultural available. Green Relief sees new recreational cannabis opportunities as a fallback position and intends to focus its production on its medical patients. LeBlanc shares that the company has the purest, highest concentration, and widest spectrum of any CBD products on the market.

Original article: VIDEO: Green Relief Inc President Steve LeBlanc on Aquaponic Growing

©2018 Midas Letter. All Rights Reserved.

Braingrid Corporation is a wireless monitoring company providing real time updates for cannabis producers. CEO Michael Kadanoff explains that Braingrid’s technology captures environmental metrics such as humidity, temperature, and CO2 levels but also provides operational oversight to detect issues in other areas of production such as hvac systems, curing rooms, and server rooms, before costly problems arise. Consequently, Braingrid’s subscription-based system allows cannabis producers to reduce costs and risk while ensuring product compliance. The company has data analytics partnerships with several companies, including Beleave Inc (CNSX:BE) (OTCMKTS:BLEVF) (FRA:4B9) and WeedMD Inc (CVE:WMD) (OTCMKTS:WDDMF) (FRA:4WE) to launch an AI platform that combines yield, environmental, and operational information to isolate best practices. Braingrid recently raised $2 million through a private financing round and is going public in early November.

Original article: VIDEO: Braingrid Corporation Cannabis Industry Ancillary Services First Mover

©2018 Midas Letter. All Rights Reserved.

Khiron Life Sciences (CVE:KHRN) President Chris Naprawa weighs in on the significance of the global cosmetic opportunity as it relates to cannabis.

James West:    Hey, welcome back. My guest in this segment is Chris Naprawa. He is the President of Khiron Life Sciences Corp., trading on the TSX Venture under symbol KHRN. Chris, welcome back.

Chris Naprawa: Thank you, thank you for having us.

James West:    Chris, you put out a fantastic press release today, at least by my estimation, that you have achieved Mexican retail distribution for your Kuida CBD cosmeceutical brand, and that obviously has huge implications given that Mexico had a population of 120 million. Tell me how, what portion of that population is going to have access to this product? What kind of sales do you anticipate?

Chris Naprawa: Yeah, so we launched the Kuida brand about a month ago in Colombia; we’ve been picked up in a couple of different pharmacies, we’ve got good distribution online plus our own branded online portal to purchase Kuida products, and this is an example how, if you have a good base in Latin America, you can extend it to other regions in Latin America. So Farmalisto, which is one of our partners in Colombia, they can just easily pick up the sku and start selling that in Mexico.

So we’re still pending some government approvals, because they just put out the guidelines yesterday, but we were anticipating those; they look just like we thought they might look, and we’re ready to have a product that will fit well within those guidelines.

James West:    Hmm. So then, it’s available from anywhere in Mexico, online?

Chris Naprawa: Correct.

James West:    And what about physical store locations?

Chris Naprawa: Stay tuned.

James West:    Stay tuned, okay!

Chris Naprawa: So Kuida for us right now is just eight skus, and I think as you see us develop, we’ll add more and more skus and beyond just cosmetics, sort of, you know, in the general wellness category. That would include beverages in that line, that would include other things in that line. Kuida, we have a fantastic marketing team with amazing leadership, and we’re going to rapidly expand beyond Colombia and Mexico. You’ll see another region from us shortly.

James West:    Okay. So the current eight skus, what sort of is the product range within those eight skus?

Chris Naprawa: So we call those cosmeceuticals. The active ingredient is called CBDerm, which is our own branded ingredient, and it’s a line of wellness products geared towards women. Latin American women spend an absolute fortune on cosmetics on a per capita basis; Mexico is no exception to that. So we’re focused on a market where there’s already high spending, they’re looking for changing, looking for alternatives. All natural, with the natural attributes that CBD brings as far as hydration, anti-inflammatory, etcetera. So we can make product around

Origin House (CNSX:OH) (OTCMKTS:ORHOF) (FRA:CY4) CEO Marc Lustig discusses how the company’s recent name change from CannaRoyalty to Origin House better fits its current direction and indicates its aim to be a premier ‘house’ of cannabis brands. Lustig emphasizes that the company is focused on distribution and branded products in the crowded California market because once it dominates that space, Origin House will have the experience and knowledge to branch out across the country. Lustig shares his opinion on the post-Sessions resignation news and indicates that Origin House has planned its production for a landscape that includes de-prohibition and legalization. However, he suggests that federal de-prohibition is still a few steps away and that the STATES Act is the next likely advancement at the federal level. Lustig ends the segment by underscoring the opportunity the US cannabis space represents, noting that the US market is 20 times bigger than the Canadian but has 1/20th the number of cannabis companies.

Original article: VIDEO: The Evolution of Origin House (CNSX:OH) Formerly CannaRoyalty Corp

©2018 Midas Letter. All Rights Reserved.

Analyst Dmitry Zaytsev shares his thoughts on the recent economic downturn. Specifically, he addresses the current slide in the cannabis space and suggests investors aligned themselves with the growing opportunities in the US cannabis space. Zaytsev believes Organigram Holdings Inc (CVE:OGI) (OTCMKTS:OGRMF) (FRA:0OG) is a bargain at its current price and is personally interested in HEXO Corp (TSE:HEXO) (OTCMKTS:HYYDF) (FRA:74H) and CannTrust Holdings Inc (TSE:TRST) (OTCMKTS:CNTTF) (FRA:C9S) because both have potentially lucrative partnership deals. He believes the next industry catalyst will be when Canadian recreational sales numbers are released in a few months. Zaytsev also explains investing strategies and indicates the current market would be a good time to write puts and calls.

Original article: VIDEO: Analyst Dmitry Zaytsev Discusses Investment Strategies in an Uncertain Cannabis Market

©2018

CB1 Capital Management CIO Todd Harrison discusses the impact of the US midterm elections on the American cannabis space and the industry more broadly. Harrison suggests the midterms will be positive for cannabis producers and users and indicates that the result of Michigan’s cannabis ballot question might illustrate the direction the nation is headed in terms of legalization. He believes the market downturn the industry experienced in October is part of the process of moving from retail to institutional investors. Harrison is still enthusiastic about investment opportunities in the space, pointing to the numerous international markets coming online and believes the medical side has significant untapped potential. Harrison expects the large Canadian companies to make accretive deals as soon as the US decriminalizes; however, he anticipates five to seven industry leaders in the North American cannabis space.

Original article: VIDEO: CB1 Capital Management CIO Discusses how Midterm Elections Impact US Cannabis Landscape

©2018 Midas Letter. All Rights Reserved.

Carube Copper Corp (CVE:CUC) CEO Stephen Hughes talks about the potential for an increase in copper prices as the world’s copper deficit grows. Hughes points to international political and economic disagreements as the reasons copper prices have continued to decrease despite soaring demand and dwindling supply. Carube has 30 ongoing projects in Jamaica and is currently focused on its gold discovery in the Main Ridge area. Carube is also searching globally for additional copper assets in anticipation of an industry rebound. While Hughes believes copper prices will soar next year, the resource’s depressed value has hurt junior mining companies, which also affects supply.

Original article: VIDEO: Carube Copper Corp (CVE:CUC) CEO Expects Copper Prices to Soar in 2019

©2018 Midas Letter. All Rights Reserved.

Private Investor Danny Moses, featured in the 2015 film The Big Short, discusses investment opportunities in the cannabis space. He has been a long-time supporter of the cannabis industry and hasn’t “ever seen an opportunity like this, from an investment perspective, in my life.” Moses works with Merida Capital, which invests in the ancillary cannabis space. Moses shares his thoughts on potential US cannabis catalysts such as the US Midterm elections and the Farm Bill. He anticipates significant consolidation in the US market when cannabis is deregulated or legalized at the federal level. Consequently, he believes US cannabis companies with strong regional operations such as Liberty Health Sciences Inc (CNSX:LHS) (OTCMKTS:LHSIF) (FRA:S6UQ) or who have undertaken significant vertical integration and consolidation, like iAnthus Capital (CNSX:IAN) and MPX Bioceutical (CNSX:MPX), will become major national players.

Original article: VIDEO: The Big Short’s Danny Moses: Cannabis is the Investment Opportunity of a Lifetime

©2018 Midas Letter. All Rights Reserved.

Emblem Corp (CVE:EMC) (OTCMKTS:EMMBF) (FRA:E0M) CEO Nick Dean has nothing but praise for the performance of the company’s recreational brand, Symbl, since legalization. Emblem focused on key Canadian rec markets in Alberta, Ontario, and Saskatchewan and has fulfilled 100 percent of its supply commitments. Dean credits the company’s marketing strategy of supplying large quantities of 1 gram packs to provincial retailers, allowing customers to try Symbl products with less risk, as a brand advantage and key to Symbl’s success. Emblem has finalized its agreement with Acnos Pharma to launch Emblem Germany and is finishing construction on its product innovation centre and GMP certified lab in Paris, Ontario. Emblem expects to use this facility to export cannabis to Germany beginning in Q3 of 2019.

Original article: VIDEO: Emblem Corp (CVE:EMC) Symbl Brand Leader in Recreational Market

©2018 Midas Letter. All Rights Reserved.